SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-20-000126
Filing Date
2020-07-31
Accepted
2020-07-30 21:58:04
Documents
48
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20200630.htm   iXBRL 10-Q 1216480
2 EX-31.1 exhibit31-1q22020.htm EX-31.1 10346
3 EX-31.2 exhibit31-2q22020.htm EX-31.2 10348
4 EX-32.1 exhibit32-1q22020.htm EX-32.1 4712
5 EX-32.2 exhibit32-2q22020.htm EX-32.2 4506
  Complete submission text file 0001125345-20-000126.txt   4960961

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20200630.xsd EX-101.SCH 31895
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20200630_cal.xml EX-101.CAL 45210
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20200630_def.xml EX-101.DEF 188970
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20200630_lab.xml EX-101.LAB 411193
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20200630_pre.xml EX-101.PRE 290130
11 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20200630_htm.xml XML 818169
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 201063501
SIC: 2834 Pharmaceutical Preparations